The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saurwein-Teissl, M.
Right arrow Articles by Grubeck-Loebenstein, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saurwein-Teissl, M.
Right arrow Articles by Grubeck-Loebenstein, B.
The Journal of Immunology, 2002, 168: 5893-5899.
Copyright © 2002 by The American Association of Immunologists

Lack of Antibody Production Following Immunization in Old Age: Association with CD8+CD28- T Cell Clonal Expansions and an Imbalance in the Production of Th1 and Th2 Cytokines1

Maria Saurwein-Teissl*, Thomas L. Lung*, Florentine Marx*, Claudio Gschösser*, Esther Asch*, Imrich Blasko*, Walther Parson{dagger}, Günther Böck{ddagger}, Diether Schönitzer§, Emanuelle Trannoy and Beatrix Grubeck-Loebenstein2,*

* Institute for Biomedical Aging Research of the Austrian Academy of Sciences, and {dagger} Institute of Legal Medicine, {ddagger} Institute of Pathophysiology, § Central Institute for Blood Transfusion, University Clinics Innsbruck, Innsbruck, Austria; and Aventis-Pasteur, Marcy l’Etoile, France


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Although it is generally recognized that the function of the immune system declines with age, the nature of the underlying defects is still poorly understood. We now demonstrate the predominance of CD8+CD28- T cell clonal expansions in elderly persons who fail to produce specific Abs following influenza vaccination. These clones express effector cell markers and are mostly CD45RA+. When isolated and put into culture, they are unable to proliferate, but produce IFN-{gamma} (but no IL-5) upon stimulation with anti-CD3 or autoantigen. These autoreactive CD8+ type 1 effector cells seem to trigger a Th1 polarization, as CD4+ T cells from elderly persons without in vivo Ab production produce Th1, but only low amounts of Th2 cytokines upon in vitro stimulation with PHA. Therefore, the increased occurrence of CD8+CD28- clonal expansions may be decisive for the development of immune deficiency in the elderly.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The function of the immune system declines with age (1, 2). This leads to increased frequency and severity of infectious diseases and endangers the protective effect of vaccination (3, 4). Decreased Ab production and shortened duration of protective immunity following immunization are characteristic features in the elderly (5, 6). Despite intensive research work, many of the basic mechanisms of age-related immune dysfunction have not yet been clarified. This is presumably due to the fact that many published reports conflict on theoretically important points. For instance, the production of the type 1 cytokine IFN-{gamma} has been reported to be high (7, 8) or low (9, 10, 11) during aging and multiple similar examples could be given (12). Controversial observations may result from variations among species, strains, organs, or culture systems, but may also be due to interindividual differences in the course of the biological aging process. To circumvent the problems of heterogenous cohorts and large deviations, we have made use of the fact that influenza vaccination induces protective Abs in only 40 to maximally 70% of the elderly (13, 14) and selected a very homogenous "model" cohort of elderly persons, none of whom produced specific Abs 1 mo after influenza vaccination. Other vaccination types might have been equally suitable to define elderly persons with a lack of Ab production following immunization, but influenza vaccination is most frequently performed and easy to monitor.

Using this special cohort, we demonstrate that lack of Ab production following immunization is associated with the increased occurrence of expanded autoreactive CD8+CD28- T cell clones. These clones, which are frequently CD45RA+, produce large amounts of IFN-{gamma} which might be the basis for a change in the polarization of the immune system in elderly persons and the development of age-related immune deficiency.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Volunteers

A total of 27 elderly (>60 years), apparently well, mentally alert persons who live in the community were included in the study. These persons had been selected from a cohort of 78 elderly persons on the basis of their Ab response to influenza vaccination with a commercially available trivalent split vaccine (Vaxigrip; Aventis-Pasteur, Paris, France) that contained influenza virus of the A/Sydney/184/93, the A/Beijing/262/95, and the B/Beijing/184/93 strain (similar to B Harbin). A total of 13 persons (6 females, 7 males, mean age 68 ± 9; range 61–89 years) were chosen who had failed to raise a humoral immune response to all three influenza strains present in the vaccine and had Ab titers below the protective level of 1:40 1 mo after vaccination. These elderly persons are in the whole manuscript referred to as "old nonresponders" (ONR)3. Aged persons (5 females, 9 males, mean age 67 ± 7; range 61–85 years) who did not have influenza-specific Abs before vaccination, but titers of >=1:40 to all three influenza strains 4 wk after vaccination were chosen as a humoral responder group and are in the manuscript referred to as "old responders" (OR). Six people from the ONR and seven from the OR group had previously been immunized against influenza. Six young healthy adults (Y; 3 females, 3 males, mean age 31 ± 3; range 28–35 years), who did also not have influenza-specific Abs before, but Ab titers of >=1:40 1 mo after vaccination were chosen as a young control group. Four of the six young people had previously been immunized against influenza. All participants had given their informed written consent and the study was approved of by the local ethical committee.

Blood samples

Peripheral blood was taken by venipuncture at three different time points, before as well as 1 and 12 mo after influenza vaccination. Serum samples (5 ml) were obtained before as well as 1 mo after vaccination. Before bleeding, a health check was performed in each participant. Preparation of PBMC was performed by Ficoll-Paque gradient centrifugation as previously described (15). Purified cells were stored in liquid nitrogen until pre- and postvaccination Ab titers had been assessed and the final selection of participants had been made. PBMC samples obtained before vaccination were used to perform the full set of experiments in all donors. In two to four people from each group, complementarity-determining region (CDR)3 spectratyping and phenotypic analysis were repeated using cells obtained 1 and 12 mo after vaccination.

Ab titers

Ab responses to the vaccine hemagglutinin components were determined by standard hemagglutination inhibition assay as described previously (15).

Cell culture reagents

The following reagents were used for in vitro cultures: FCS (SEBAK, Stuben, Austria), RPMI 1640 (Life Technologies, Grand Island, NY), PHA (20 ng/ml; Sigma-Aldrich, St. Louis, MO), live influenza virus (kindly provided by Berna, Swiss Serum and Vaccine Institute, Berne, Switzerland), live CMV (kindly provided by Dr. H. P. Huemer, University of Innsbruck, Innsbruck, Austria), live EBV (diluted supernatant; kindly provided by D. Kraft, University of Vienna, Vienna, Austria), and OKT-3 (20 ng/ml; American Type Culture Collection, Manassas, VA).

Flow cytometry

Cells were preincubated with an Fc block (mAb to CD16-CD32, 2.4G2; BD PharMingen, San Diego, CA) and washed in FACS buffer (PBS, 0.5% BSA, 0.01% sodium azide). Next, they were incubated with specific Ab directly conjugated as described below, washed, and analyzed using FACScan, FACSort, and FACSCalibur cytometers; and data were analyzed with CellQuest software (BD Biosciences, San Jose, CA). The mAbs used were purchased from BD PharMingen: CD4 (CyChrome-, PerCP-, or allophycocyanin-labeled), CD8 (CyChrome-, PerCP-, or allophycocyanin-labeled), CD3 (PE-labeled), CD11a (PE-labeled), CD28 (FITC- or CyChrome-labeled), CD45RO (FITC- or PE-conjugated), CD45RA (FITC- or CyChrome-labeled), CD95 (FITC-conjugated), CD16 (PE-labeled), V{beta}1 (PE-labeled), V{beta}5 (PE-labeled), V{beta}9 (FITC-labeled), and V{beta}17 (PE-labeled).

Purification of T cells

CD4+ and CD8+ T cells were purified as follows. PBMC were passed through a nylon mesh. CD4+ and CD8+ T cells were then purified by a positive selection procedure using anti-CD4+/CD8+-labeled microbeads and the MACS system (Miltenyi Biotec, Bergisch Gladbach, Germany) (purity: 97 ± 3% CD4+/CD8+/CD3+ cells, range 92–100%). For the isolation and characterization of expanded T cell clones, CD4- cells were stained with anti-CD8 and V{beta}-specific anti-TCR Abs and double-positive T cells were sorted with a FACS sorter. Only clones that dominated one V{beta} family in a way that no other clones were visible (diversity score 3, see CDR3 spectratyping) were selected for purification. The selected T cells were then washed, phenotyped, and placed into culture. The clonal nature of the selected cells was confirmed by immunoscope technology and sequencing.

RNA and cDNA preparation

Total RNA was extracted from T cells using Tri Reagent (Sigma-Aldrich). A total of 1 µg of total RNA was used for first-strand cDNA synthesis using a Reverse Transcription system (Promega, Madison, WI). TCR V{beta} transcripts were amplified by PCR using primers (Life Technologies, Vienna, Austria) specific for each of the human V{beta} families and a specific primer for the constant region of the {beta}-chain (labeled with the fluorescent dye marker 6-FAM).

CDR3 spectratyping

An aliquot of the PCR product was diluted in 16 µl deionized formamide and 1.2 fmol internal lane standard GeneScan-350 Tamra (PerkinElmer, Norwalk, CT). The samples were denatured at 90°C for 2 min and snap cooled on ice before loading on a CE 310 Genetic Analyzer (PerkinElmer). Each sample was injected for 5 s at 15 kV and electrophoresed for 24 min at 10 kV using a 36-cm capillary and POP4 (PerkinElmer). Analysis of the raw data was performed applying the GeneScan 2.1 analysis software package (PE Applied Biosystems, Foster City, CA) using the Local Southern method for fragment size estimation. In the case of a normal distribution of individual clones within the V{beta} family, a Gaussian profile was depicted. Deviations from the Gaussian profile indicated the presence of large expanded clones. The occurrence of dominant clonal expansions within the different V{beta} families was quantified by using a diversity score between 1 and 3; 1 was assigned to a Gaussian distribution, 2 corresponded to a pattern with one to three peaks above the Gaussian background, and 3 corresponded to one predominant peak above the Gaussian distribution (Fig. 1Go). The mean of all scores assigned to the clonal distributions within the different V{beta} families was then calculated for each individual blood donor for CD4+, as well as CD8+ cells. These individual scores were then used for further analysis, when the clonal diversity of CD4+ and CD8+ cells in the different groups (Y, OR, ONR) was assessed. The classification of CDR3 spectratypes as Gaussian, oligoclonal, or monoclonal was done "blind" by three different persons. The ratings were then compared. In the rare case of discrepancies, the assessment made by two of the three investigators was used for further calculations. Three different opinions never occurred.



View larger version (35K):
[in this window]
[in a new window]
 
FIGURE 1. Clonal expansions dominate the CD8+ T cell repertoire in elderly persons who fail to produce protective Abs following influenza vaccination. a, cDNA made from total RNA extracted from CD4+ or CD8+ cells was amplified and primed by V{beta} subfamily specific primers and a fluorescence-labeled primer specific for the constant region of the V{beta}-chain as described in Material and Methods. The labeled DNA copies were analyzed on an automated DNA sequencer. The fluorescence patterns were obtained with the help of GeneScan 2.1 analysis software. Six randomly chosen V{beta} families are shown for one donor from each group. b, Using the diversity score described in Material and Methods (inset) statistical analysis demonstrated a higher frequency of deviations from the Gaussian profile in the CD8+ T cell pool of the ONR group than in the OR and in the Y group; the bars represent means ± SEM; n = 6 in the Y, n = 14 in the OR, and n = 13 in the ONR group. In each individual person, the score used for calculation presented a mean of all V{beta} families (p < 0.05: *, vs Y; °, vs OR).

 
TCR sequencing

Individual V{beta} families that were seemingly dominated by one expanded clone were selected and amplified by PCR. The clonal nature of the observed expansions was confirmed by DNA sequencing. Purified PCR products were ligated with pCRScriptAmp SK vector (Cloning kit; Stratagene, La Jolla, CA) for 60 min at room temperature. One Shot competent cells (Invitrogen, San Diego, CA) were used for the transformation. After PCR screening, positive colonies were selected and expanded. Plasmids were purified, digested with restriction enzymes, and the inserts were sequenced using an ABI Prism Genetic Analyzer CE 310 (PE Applied Biosystems) DNA sequencer. The sequence data were analyzed using GeneScan Analysis Version 2.1 software.

Cell culture

FACS sorted and isolated T cell clones were cultured together with equal numbers of autologous irradiated (35 Gy) PBMC as APC at a density of 5 x 104 cells/well in 96-well plates in the presence or absence of different stimuli as previously described (16). Cells and conditioned supernatants were harvested after 6 days.

Purified CD4+ T cells were seeded at a density of 106 cells/well in 24-well plates (Falcon; BD Biosciences) together with 106 autologous irradiated (35 Gy) PBMC and stimulated with PHA. Cells and conditioned supernatants were collected after 6 days for cytokine analysis.

Cytokine determinations

Cytokine concentrations in conditioned supernatants were assessed by commercially available ELISA kits (CYTELISA; Cytimmunesciences, Vienna, Austria). IFN-{gamma} was analyzed as a characteristic type 1, and IL-5 as a characteristic type 2 cytokine.

Statistical analysis

All statistical analyses were based on Student’s t tests for paired and unpaired data. Differences in Ab titers between the groups were assessed by Fisher’s exact test.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Responders and nonresponders to influenza vaccination

Elderly persons were selected who did not produce protective Abs 1 mo after influenza vaccination. This group is in the following referred to as ONR. Two groups were chosen as controls: elderly persons who did produce protective Abs to influenza following vaccination (OR), and a cohort of young persons (Y) who had a satisfactory humoral immune response to influenza vaccination. None of the persons studied had Abs specific to the three influenza strains present in the vaccine before vaccination. Postvaccination Ab titers in the respective groups are listed in Table IGo.


View this table:
[in this window]
[in a new window]
 
Table I. Geometric mean anti-influenza hemagglutinin Ab titers (GMT) 4 wk after influenza vaccination1

 
Clonal expansions dominate the CD8+ T cell repertoire in elderly persons who fail to produce protective Abs following influenza vaccination

The clonal composition of the different CD8+ and CD4+ TCR families was studied in the three donor groups. Immunoscope technology was applied. A representative example of results obtained with this technique is depicted in Fig. 1Goa. In the CD4+ population, V{beta} subfamilies had a Gaussian or close to Gaussian CDR3-size distribution pattern in all three groups. Clear deviations from the Gaussian profile were only noted in the V{beta} families in the CD8+ population. Pronounced differences among the groups were observed. Although the Gaussian profile was most frequently observed in young persons, deviations from the Gaussian profile were often present in both elderly groups, but were more pronounced in the ONR group (Fig. 1Go, a and b). All V{beta} families were equally affected. Single large expanded clones dominating a V{beta} family (diversity score 3) were detected in 2 of 6 (33%) of the young control persons, and in each person in both elderly groups. However, their frequency was higher in the ONR group, in which the shift affected a large majority of V{beta} families in all but one person. In this person, 50% of the V{beta} families were affected. Fifty percent of the V{beta} families were also dominated by single peaks in one member of the OR group, while the frequency of expanded clones was lower in all other members of this group. One of the two young people who had dominant peaks in their CD8+ repertoire showed a pattern similar to elderly responders, while dominant peaks were very rare in the other one. In two donors from each group, CDR3 spectratyping was repeated 1 mo and 1 year after vaccination. However, no alterations from the original pattern were observed in any of the samples studied.

Clonal expansions which dominate the CD8+ repertoire have a CD28-CD11a++(bright)CD95++(bright) phenotype and produce IFN-{gamma}, but no IL-5 in response to stimulation with autologous cells

To learn more about the phenotypic and functional characteristics of expanded T cell clones, clones which dominated a V{beta} family and were also stably detected over a year (Fig. 2Goa) were isolated by cell sorting (Fig. 2Gob). Seven clones from five donors (one Y, two OR, and two ONR) were obtained. Characterization of the sorted cells by immunoscope technology always demonstrated one large peak identical in size to the one observed before sorting (Fig. 2Goc). The identity of the clones at different time points as well as before and after sorting was additionally confirmed by cloning and sequencing. All sorted clones expressed CD11a and CD95 at high density (Fig. 3Goa). However, they did not express CD28. Five of the seven clones (71%) were CD45RA+, and two (29%; one from a donor from the Y, the other one from a donor from the OR group) contained CD45RA+ as well as CD45RO+ cells. The sorted clones retained their phenotype in cell culture in the absence of stimuli over an observation period of 2 wk. During this time the cells stayed viable, but failed to increase in number. Cytokine secretion analysis demonstrated that the clones produced IFN-{gamma}, but failed to secrete the type 2 cytokine IL-5 in response to stimulation with irradiated autologous PBMC (Fig. 3Gob). Thus, they were autoreactive, although due to the low numbers of sorted cells available, the exact nature of the autoantigen could not be defined. IFN-{gamma}, but no IL-5, was also secreted when the cells were stimulated with OKT-3; but no cytokines were produced when irradiated allogeneic PBMC were used as stimulus. No increase in the production of IFN-{gamma} by the clones took place when the autologous PBMC which were used as APC were pulsed with a panel of different Ags including influenza virus, CMV, or EBV. IFN-{gamma} production was not accompanied by proliferation. There was no difference in the cytokine secretion pattern between clones from the Y, the OR, and the ONR donor groups, or between CD45RA+ clones and clones that also contained CD45RO+ cells (data not shown). These data indicated that the phenotypic and functional characteristics of the expanded clones were more or less the same, but that their frequency was different in the three donor groups.



View larger version (13K):
[in this window]
[in a new window]
 
FIGURE 2. Identification and sorting of expanded clonotypes. a, Stability of a CD8+V{beta}5+ clonal expansion. CDR3 size distribution analysis was performed twice at a year’s interval. At both time points, the monoclonal composition of the peak was confirmed by cloning and sequencing. b, Sorting process of the T cell clone stained with CD8 and V{beta}5 on a fluorescence-activated cell sorter. c, CDR3 size distribution profile of the selected T cells after sorting. The identity with the presorting population was again confirmed by cloning and sequencing. The figure depicts one of seven similar experiments. A clone from a donor from the ONR group is shown.

 


View larger version (25K):
[in this window]
[in a new window]
 
FIGURE 3. Phenotypic and functional characterization of expanded clonotypes. Phenotyping (a) and cytokine production profile (b) of an isolated T cell clone. The sorted cells expressed CD8, CD11a, CD95, and CD45RA, but not CD28. In culture, they secreted IFN-{gamma}, but no IL-5 following stimulation with irradiated autologous PBMC and OKT-3; but there was no response to allogeneic PBMC. The figure shows the phenotype and the cytokine production profile of the clone depicted in Fig. 2Go. Similar results were obtained when six other isolated clones were characterized.

 
The predominance of CD45RA+CD28-CD11a++(bright)CD8+ clones is reflected in the phenotype of PBMC from elderly people who fail to produce protective Abs following influenza vaccination

To define whether the predominance of expanded clones observed in the ONR group was reflected in the phenotype of PBMC, we analyzed the expression of CD28 and of CD45RA and CD45RO on peripheral CD4+ and CD8+ lymphocytes. Although the percentage of CD4+CD28- cells was low in all three groups, CD8+ cells were frequently CD28-, and there was a clear cut difference in the number of CD8+CD28- cells among the groups (Fig. 4Goa). Within the CD8+CD45RO+ population, CD28- cells were more frequent in both the OR and the ONR group than in the young group. In contrast, the percentage of CD28- cells within the CD8+CD45RA+ population was markedly higher in the ONR than in the OR group. CD8+CD45RA+CD28- cells coexpressed CD11a at high intensity (Fig. 4Gob). They did not express CD16. Thus, they were most likely effector T cells with a CD45RA phenotype, and corresponded to the predominant clonotypes described above. Phenotypic analysis was repeated 1 mo and 1 year after vaccination in two to four donors from each group. No significant changes from the original prevaccination samples were observed in these donors.



View larger version (28K):
[in this window]
[in a new window]
 
FIGURE 4. PBMC analysis: the frequency of peripheral CD45RA+CD28-CD11a++(bright)CD8+ cells increases with age and is highest in elderly persons who fail to produce protective Abs following influenza vaccination. a, Triple staining and FACS analysis of CD28 on CD45RO+ and CD45RA+ cells in the CD4+ and the CD8+ T cell population. The bars represent the percentage of CD28- cells in the 1) CD4+CD45RO+, 2) CD4+CD45RA+, 3) CD8+CD45RO+, and 4) CD8+CD45RA+ populations, which were each considered as 100% (means ± SEM; n = 6 in the Y, n = 14 in the OR, and n = 13 in the ONR group); p < 0.01; *, vs Y; #, vs OR. b, Representative FACS profile of a quadruple staining experiment on the coexpression of CD28 and CD11a on CD4+CD45RA+ or CD8+CD45RA+ cells. The figure depicts one of five similar experiments. The quadrants are set in a way to distinguish between CD11a+(dim) and CD11a++(bright) cells. Cells from a donor from the ONR group are shown.

 
CD4+ cells from elderly persons who fail to produce protective Abs following influenza vaccination have a decreased production of IL-5 following in vitro stimulation with PHA

As the predominance of IFN-{gamma} producing autoreactive CD8+ T cell clones may lead to a polarization of immune responses in the direction of Th1 responses, CD4+ T cells were studied for their cytokine production. CD4+ cells were purified from PBMC and stimulated with PHA. Conditioned supernatants were tested for the presence of IFN-{gamma} and IL-5. Following PHA stimulation, the secretion of IL-5 was similar in the Y and in the OR group, but significantly lower in the ONR group (Fig. 5Go). In contrast, IFN-{gamma} production did not differ among the groups, suggesting an imbalance in the production of Th1 and Th2 cytokine in elderly persons, who fail to produce Abs following influenza vaccination.



View larger version (30K):
[in this window]
[in a new window]
 
FIGURE 5. CD4+ cells from elderly persons who fail to produce protective Abs following influenza vaccination have a decreased production of IL-5. Purified CD4+ cells were seeded together with irradiated autologous PBMC and stimulated with PHA. Supernatants for the analysis of IFN-{gamma} and IL-5 by ELISA were collected after 6 days of culture. Bars represent means ± SEM (n = 6 in the Y, n = 14 in the OR, and n = 13 in the ONR group); *, p < 0.05 vs Y and vs OR.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Our results show that expanded CD28- T cell clones dominate the CD8+ repertoire in persons who fail to produce protective Abs following influenza vaccination. These clones produce large amounts of IFN-{gamma} upon autoantigenic stimulation. However, they do not produce IL-5. Frequent and ubiquitous restimulation by autoantigen could be a reason for the persistence of these clones in vivo (Fig. 3Go), and represent a possible basis for a relative overproduction of IFN-{gamma} in old age. Many studies which consistently report that neopterin (a macrophage product the production of which is exclusively triggered by IFN-{gamma}) is elevated in the elderly support this possibility (17, 18, 19, 20). Measuring the production of Abs of the IgG2a istoype could be another way to assess the functional consequences of IFN-{gamma} production in the elderly. A high type 1 cytokine production could change the cytokine microenvironment in lymphatic tissues, and thus be responsible for a decreased production of type 2 cytokines by CD4+ T cells (Fig. 5Go). Type 2 cytokines act on B cells to induce activation and differentiation, whereas low type 2 cytokine production is likely to hamper B cell propagation, and thus may be responsible for a decreased production of Abs following immunization in the elderly. A recent study in aged mice, which fail to raise a Th2 response following in vivo challenge, is also in favor of this concept (21). It would also be of interest to test whether CD28- clones might have a direct effect on the differentiation and polarization of CD4+ cells. Experiments presently underway in our laboratory, in which the cytokine production pattern of cocultured CD4+ and CD8+ T cells is tested, will help to elucidate this possibility.

Th1 polarization may not only be a problem in the context of decreased Ab production in old age, but may also be detrimental for other reasons. Proinflammatory cytokines are now believed to exacerbate the functional pathology and disease course of age-related disorders, such as Alzheimer’s disease (22, 23) and atherosclerosis (24). IFN-{gamma} triggers the production of the Alzheimer {beta} amyloid (A{beta}) in combination with TNF-{alpha} by human neural and extraneural cells (25), and increases the production of oxygen radicals by microglial cells (26). TNF-{alpha} can also increase the toxicity of A{beta} (27) as well as stimulate smooth muscle cell proliferation (24), a key event in the development of atherosclerosis.

Although the etiology of CD28- T cells is not fully understood in healthy individuals, there is strong evidence that these cells have arisen in response to continued antigenic stimulation (28, 29). CD28 expression is characteristically lost after many rounds of cell division (30), and the strong expression of CD11a on CD28- cells (Figs. 3Go and 4Gob) is also consistent with their prior activation by Ag. Telomere shortening has also been described in CD28- T cells and is more pronounced than in CD28+ cells from the same donor (31, 32). This also indicates that the former have undergone more rounds of cell division than the latter.

It is striking that CD28- memory/effector cells mostly have a CD45RA phenotype in people who fail to produce specific Abs following influenza vaccination. CD28-CD45RA+ memory/effector T cells have previously been described to occur at increased frequency in old age, but their origin and significance were unclear (7, 33). It seems now likely that the CD28-CD45RA+ phenotype is consistent with a state of terminal effector cell differentiation (34), although its role as a reservoir of long-lived memory cells has also been discussed. Characteristics such as a loss of growth potential (7) and an increased resistance to apoptosis-inducing stimuli (35, 36), which are reminiscent of the well-defined phenotype of senescent fibroblasts or keratinocytes (37, 38), do in any case suggest that CD28-CD45RA+ T cells can be considered as truly "old."

The accumulation of expanded CD28- clones of old effector/memory T cells in elderly persons could lead to a restriction of the space still available for functioning T cells. This could be another cause for the development of age-related immune deficiency (39). In this context, it seems of interest that predictions of longevity have been made based on the ratio of naive vs memory T cells. Thus, mice characterized by relatively low levels of CD4 and CD8 memory cells and high levels of CD4 naive cells lived longer than conventional controls (40). No information is presently available on the presence or absence of clonal expansions in the CD8+ T cell pool of these long-lived mice, but age-related clonal T cell expansions have also been demonstrated in rodents (41). These animal studies in combination with our present data support the concept that the number of memory cells, or more precisely the number of CD28-CD45RA+CD8+ T cells could be used as a biomarker of immune senescence in middle-aged and elderly humans. Work presently underway in our laboratory will demonstrate whether aged persons with a high proportion of CD28-CD45RA+CD8+ T cells in their peripheral blood are also likely to have a low humoral immune response to vaccines such as tetanus, diphtheria, or rabies.

In conclusion, our data illustrate the accumulation of CD8+CD28- IFN-{gamma} producing T cells in the aging immune system. Due to their special properties, these cells may drive a Th1 polarization. Of course, we realize that our data make only an indirect case for cause and effect at this time and that we still have to prove that poor in vivo Ab responses are due to effects of the CD28- cells on CD4 cell differentiation. The possibility that CD8+ clones and low Ab production may both be due to the same underlying alteration that contributes to differences in several signs of immune aging cannot yet be ruled out. It is still tempting to speculate that an imbalance in the production of pro- and anti-inflammatory cytokines could diminish the chances of elderly persons to be protected from infectious diseases, and increase their likelihood to develop age-related disorders, such as Alzheimer’s disease and atherosclerosis.


    Acknowledgments
 
We thank P. Beverley, C. Franceschi, J. Evans, and M. Weksler for many stimulating discussions; and B. Jenewein, R. Muehlmann, and A. König for their excellent technical assistance.


    Footnotes
 
1 This work was supported by the European Union (project "Immunology and Ageing in Europe"-IMAGINE, contract no. QLK6-CT-1999-02031), and by the Austrian Federal Ministry of Science and Transport (GZ 70.062/2-Pr/4/99). Back

2 Address correspondence and reprint requests to Dr. Beatrix Grubeck-Loebenstein, Immunology Division, Institute for Biomedical Aging Research of the Austrian Academy of Sciences, Rennweg 10, A-6020 Innsbruck, Austria. E-mail address: Beatrix.Grubeck{at}oeaw.ac.at Back

3 Abbreviations used in this paper: ONR, old nonresponder; OR, old responder; Y, young healthy adult; CDR, complementarity-determining region. Back

Received for publication November 21, 2001. Accepted for publication March 19, 2002.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Wick, G., B. Grubeck-Loebenstein. 1997. Primary and secondary alterations of immune reactivity in the elderly: impact of dietary factors and disease. Immunol. Rev. 160:171.[Medline]
  2. Grubeck-Loebenstein, B., and G. Wick. 2001. The aging of the immune system. Adv. Immunol. In press.
  3. Webster, R. G.. 2000. Immunity to influenza in the elderly. Vaccine 18:1686.[Medline]
  4. Grubeck-Loebenstein, B., P. Berger, M. Saurwein-Teissl, K. Zisterer, G. Wick. 1998. No immunity for the elderly. Nat. Med. 4:870.
  5. Steger, M. M., C. Maczek, P. Berger, B. Grubeck-Loebenstein. 1996. Vaccination against tetanus in the elderly: do recommended vaccination strategies give sufficient protection. Lancet 348:762.
  6. Weksler, M. E., P. Szabo. 2000. The effect of age on the B-cell repertoire. J. Clin. Immunol. 20:240.[Medline]
  7. Bandres, E., J. Merino, B. Vazquez, S. Inoges, C. Moreno, M. L. Subira, A. Sanchez-Ibarrola. 2000. The increase of IFN-{gamma} production through aging correlates with the expanded CD8+CD28-CD57+ subpopulation. Clin. Immunol. 96:230.[Medline]
  8. Sakata-Kaneko, S., Y. Wakatsuki, T. Matsunaga, T. Usui, T. Kita. 2000. Altered Th1/Th2 commitment in human CD4+ T cells with ageing. Clin. Exp. Immunol. 120:267.[Medline]
  9. Karanfilov, C. I., B. Liu, C. C. Fox, R. R. Lakshmanan, R. L. Whisler. 1999. Age-related defects in Th1 and Th2 cytokine production by human T cells can be dissociated from altered frequencies of CD45RA+ and CD45RO+ T cell subsets. Mech. Ageing Dev. 109:97.[Medline]
  10. Mbawuike, I. N., C. L. Acuna, K. C. Walz, R. L. Atmar, S. B. Greenberg, R. B. Couch. 1997. Cytokines and impaired CD8+ CTL activity among elderly persons and the enhancing effect of IL-12. Mech. Ageing Dev. 94:25.[Medline]
  11. Rink, L., I. Cakman, H. Kirchner. 1998. Altered cytokine production in the elderly. Mech. Ageing Dev. 102:199.[Medline]
  12. Bernstein, E. D., E. D. Gardner, E. Abrutyn, P. Gross, D. M. Murasko. 1998. Cytokine production after influenza vaccination in a healthy elderly population. Vaccine 16:1722.[Medline]
  13. Gross, P. A., A. W. Hermogenes, H. S. Sacks, J. Lau, R. A. Levandowski. 1995. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann. Intern. Med. 123:518.[Abstract/Free Full Text]
  14. Nichol, K. L., K. L. Margolis, J. Wuorenma, T. Von Sternberg. 1994. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N. Engl. J. Med. 331:778.[Abstract/Free Full Text]
  15. Saurwein-Teissl, M., M. M. Steger, R. Glück, S. Cryz, B. Grubeck-Loebenstein. 1998. Influenza vaccination in a healthy geriatric population: preferential induction of antibodies specific for the H3N2 influenza strain despite equal T cell responsiveness to all vaccine strains. Vaccine 16:196.[Medline]
  16. Grubeck-Loebenstein, B., K. Trieb, A. Sztankay, W. Holter, H. Anderl, G. Wick. 1994. Retrobulbar T cells from patients with Graves’ ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts. J. Clin. Invest. 93:2738.
  17. Stulnig, T., A. Mair, E. Jarosch, M. Schober, D. Schönitzer, G. Wick, L. A. Huber. 1993. Estimation of reference intervals from a SENIEUR protocol compatible aged population for immunogerontological studies. Mech. Ageing Dev. 68:105.[Medline]
  18. Diamondstone, L. S., D. J. Tollerud, D. Fuchs, H. Wachter, L. M. Brown, E. Maloney, C. C. Kurman, D. L. Nelson, W. A. Blattner. 1994. Factors influencing serum neopterin and {beta}2-microglobulin levels in a healthy diverse population. J. Clin. Immunol. 14:368.[Medline]
  19. Catania, A., L. Airaghi, P. Motta, M. G. Manfredi, G. Annoni, C. Pettenati, F. Brambilla, J. M. Lipton. 1997. Cytokine antagonists in aged subjects and their relation with cellular immunity. J. Gerontol. A. Biol. Sci. Med. Sci. 52:93.
  20. Fahey, J. L., J. F. Schnelle, J. Boscardin, J. K. Thomas, M. E. Gorre, N. Aziz, H. Sadeghi, P. Nishanian. 2000. Distinct categories of immunologic changes in frail elderly. Mech. Ageing Dev. 115:1.[Medline]
  21. Smith, P., D. W. Dunne, P. G. Fallon. 2001. Defective in vivo induction of functional type 2 cytokine responses in aged mice. Eur. J. Immunol. 31:1495.[Medline]
  22. McGeer, P. L., E. G. McGeer. 1995. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 21:195.[Medline]
  23. McGeer, P. L., E. G. McGeer. 1996. Anti-inflammatory drugs in the fight against Alzheimer’s disease. Ann. NY Acad. Sci. 777:213.[Medline]
  24. Mensink, A., A. Brouwer, E. H. Van den Burg, S. Geurts, W. M. Jongen, C. M. Lakemond, I. Meijerman, T. Van der Wijk. 1996. Modulation of intercellular communication between smooth muscle cells by growth factors and cytokines. Eur. J. Pharmacol. 310:73.[Medline]
  25. Blasko, I., F. Marx, E. Steiner, T. Hartmann, B. Grubeck-Loebenstein. 1999. TNF{alpha} plus IFN{gamma} induce the production of Alzheimer {beta}-amyloid peptides and decrease the secretion of APPs. FASEB J. 13:63.[Abstract/Free Full Text]
  26. Viel, J. J., D. Q. McManus, S. S. Smith, G. J. Brewer. 2001. Age- and concentration-dependent neuroprotection and toxicity by TNF in cortical neurons from {beta}-amyloid. J. Neurosci. Res. 64:454.[Medline]
  27. Blasko, I., T. L. Schmitt, E. Steiner, K. Trieb, B. Grubeck-Loebenstein. 1997. Tumor necrosis factor {alpha} augments amyloid {beta} protein (25-35) induced apoptosis in human cells. Neurosci. Lett. 238:17.[Medline]
  28. Wack, A., A. Cossarizza, S. Heltai, D. Barbieri, S. D’Addato, C. Fransceschi, P. Dellabona, G. Casorati. 1998. Age-related modifications of the human {alpha}{beta} T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. Int. Immunol. 10:1281.[Abstract/Free Full Text]
  29. Fitzgerald, J. E., N. S. Ricalton, A. C. Meyer, S. G. West, H. Kaplan, C. Behrendt, B. L. Kotzin. 1995. Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J. Immunol. 154:3538.[Abstract]
  30. Effros, R.B.. 2000. Costimulatory mechanisms in the elderly. Vaccine 8:1661.
  31. Monteiro, J., F. Batliwalla, H. Ostrer, P. K. Gregersen. 1996. Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J. Immunol. 156:3587.[Abstract]
  32. Batliwalla, F., M. N. Rufer, P. M. Lansdorp, P. K. Gregersen. 2000. Oligoclonal expansions in the CD8+CD28- T cells largely explain the shorter telomeres detected in this subset: analysis by flow FISH. Hum. Immunol. 61:951.[Medline]
  33. Nociari, M. M., W. Telford, C. Russo. 1999. Postthymic development of CD28-CD8+ T cell subset: age-associated expansion and shift from memory to naive phenotype. J. Immunol. 162:3327.[Abstract/Free Full Text]
  34. Champagne, P., G. S. Ogg, A. S. King, C. Knabenhans, K. Ellefsen, M. Nobile, V. Appay, G. P. Rizzardi, S. Fleury, M. Lipp, et al 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 140:106.
  35. Schirmer, M., A. N. Vallejo, C. M. Weyand, J. J. Goronzy. 1998. Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28- T cells from rheumatoid arthritis patients. J. Immunol. 161:1018.[Abstract/Free Full Text]
  36. Spaulding, C., W. Guo, R. B. Effros. 1999. Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp. Gerontol. 34:633.[Medline]
  37. Toussaint, O., E. E. Medrano, T. von Zglinicki. 2000. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp. Gerontol. 35:927.[Medline]
  38. Campisi, J.. 1998. The role of cellular senescence in skin aging. J. Invest. Dermatol. Symp. Proc. 3:1.
  39. Beverley, P. C., B. Grubeck-Loebenstein. 2000. Is immune senescence reversible?. Vaccine 18:1721.[Medline]
  40. Miller, R. A.. 2001. Biomarkers of aging: prediction of longevity by using age-sensitive T-cell subset determinations in a middle-aged, genetically heterogeneous mouse population. J. Gerontol. A. Biol. Sci. Med. Sci. 56:180.
  41. Callahan, J. E., J. W. Kappler, P. Marrack. 1993. Unexpected expansions of CD8-bearing cells in old mice. J. Immunol. 151:6657.[Abstract]



This article has been cited by other articles:


Home page
J Gerontol A Biol Sci Med SciHome page
R. B. Effros
Kleemeier Award Lecture 2008--The Canary in the Coal Mine: Telomeres and Human Healthspan
J Gerontol A Biol Sci Med Sci, May 1, 2009; 64A(5): 511 - 515.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. T. Parish, J. E. Wu, and R. B. Effros
Modulation of T Lymphocyte Replicative Senescence via TNF-{alpha} Inhibition: Role of Caspase-3
J. Immunol., April 1, 2009; 182(7): 4237 - 4243.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. T. Clambey, J. White, J. W. Kappler, and P. Marrack
Identification of two major types of age-associated CD8 clonal expansions with highly divergent properties
PNAS, September 2, 2008; 105(35): 12997 - 13002.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S.-J. Lin, A. T. Chen, and R. M. Welsh
Immune system derived from homeostatic proliferation generates normal CD8 T-cell memory but altered repertoires and diminished heterologous immune responses
Blood, August 1, 2008; 112(3): 680 - 689.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Parsons, A. Lelic, L. Hayes, A. Carter, L. Marshall, C. Evelegh, M. Drebot, M. Andonova, C. McMurtrey, W. Hildebrand, et al.
The Memory T Cell Response to West Nile Virus in Symptomatic Humans following Natural Infection Is Not Influenced by Age and Is Dominated by a Restricted Set of CD8+ T Cell Epitopes
J. Immunol., July 15, 2008; 181(2): 1563 - 1572.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. J. C. Miles, M. van der Sande, D. Jeffries, S. Kaye, J. Ismaili, O. Ojuola, M. Sanneh, E. S. Touray, P. Waight, S. Rowland-Jones, et al.
Cytomegalovirus Infection in Gambian Infants Leads to Profound CD8 T-Cell Differentiation
J. Virol., June 1, 2007; 81(11): 5766 - 5776.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. W. Munks, K. S. Cho, A. K. Pinto, S. Sierro, P. Klenerman, and A. B. Hill
Four Distinct Patterns of Memory CD8 T Cell Responses to Chronic Murine Cytomegalovirus Infection
J. Immunol., July 1, 2006; 177(1): 450 - 458.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Galle, L. Schandene, J.-P. Dereume, M. Goldman, C. Duftner, C. Dejaco, and M. Schirmer
CD8+ T-Cell Subpopulations in Human Abdominal Aortic Aneurysm Lesion
Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): e19 - e20.
[Full Text] [PDF]


Home page
Int ImmunolHome page
R. D. Kovaiou, I. Weiskirchner, M. Keller, G. Pfister, D. P. Cioca, and B. Grubeck-Loebenstein
Age-related differences in phenotype and function of CD4+ T cells are due to a phenotypic shift from naive to memory effector CD4+ T cells
Int. Immunol., October 1, 2005; 17(10): 1359 - 1366.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Herndler-Brandstetter, S. Schwaiger, E. Veel, C. Fehrer, D. P. Cioca, G. Almanzar, M. Keller, G. Pfister, W. Parson, R. Wurzner, et al.
CD25-Expressing CD8+ T Cells Are Potent Memory Cells in Old Age
J. Immunol., August 1, 2005; 175(3): 1566 - 1574.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
A. Wikby, F. Ferguson, R. Forsey, J. Thompson, J. Strindhall, S. Lofgren, B.-O. Nilsson, J. Ernerudh, G. Pawelec, and B. Johansson
An Immune Risk Phenotype, Cognitive Impairment, and Survival in Very Late Life: Impact of Allostatic Load in Swedish Octogenarian and Nonagenarian Humans
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2005; 60(5): 556 - 565.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Almanzar, S. Schwaiger, B. Jenewein, M. Keller, D. Herndler-Brandstetter, R. Wurzner, D. Schonitzer, and B. Grubeck-Loebenstein
Long-Term Cytomegalovirus Infection Leads to Significant Changes in the Composition of the CD8+ T-Cell Repertoire, Which May Be the Basis for an Imbalance in the Cytokine Production Profile in Elderly Persons
J. Virol., March 15, 2005; 79(6): 3675 - 3683.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Ehrchen, A. Sindrilaru, S. Grabbe, F. Schonlau, C. Schlesiger, C. Sorg, K. Scharffetter-Kochanek, and C. Sunderkotter
Senescent BALB/c Mice Are Able To Develop Resistance to Leishmania major Infection
Infect. Immun., September 1, 2004; 72(9): 5106 - 5114.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Lewis, M. Merched-Sauvage, J. J. Goronzy, C. M. Weyand, and A. N. Vallejo
Tumor Necrosis Factor-{alpha} and CD80 Modulate CD28 Expression through a Similar Mechanism of T-cell Receptor-independent Inhibition of Transcription
J. Biol. Chem., July 9, 2004; 279(28): 29130 - 29138.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
M. Leslie
All Pain, No Gain
Sci. Aging Knowl. Environ., July 7, 2004; 2004(27): ns4 - ns4.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Deng, Y. Jing, A. E. Campbell, and S. Gravenstein
Age-Related Impaired Type 1 T Cell Responses to Influenza: Reduced Activation Ex Vivo, Decreased Expansion in CTL Culture In Vitro, and Blunted Response to Influenza Vaccination In Vivo in the Elderly
J. Immunol., March 15, 2004; 172(6): 3437 - 3446.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Frasca, E. Van der Put, R. L. Riley, and B. B. Blomberg
Reduced Ig Class Switch in Aged Mice Correlates with Decreased E47 and Activation-Induced Cytidine Deaminase
J. Immunol., February 15, 2004; 172(4): 2155 - 2162.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. S. Diamond, E. M. Sitati, L. D. Friend, S. Higgs, B. Shrestha, and M. Engle
A Critical Role for Induced IgM in the Protection against West Nile Virus Infection
J. Exp. Med., December 15, 2003; 198(12): 1853 - 1862.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
R. J. Davenport
Immunity Challenge
Sci. Aging Knowl. Environ., June 11, 2003; 2003(23): oa1 - 1.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. S. Diamond, B. Shrestha, A. Marri, D. Mahan, and M. Engle
B Cells and Antibody Play Critical Roles in the Immediate Defense of Disseminated Infection by West Nile Encephalitis Virus
J. Virol., February 15, 2003; 77(4): 2578 - 2586.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Schwaiger, A. M. Wolf, P. Robatscher, B. Jenewein, and B. Grubeck-Loebenstein
IL-4-Producing CD8+ T Cells with a CD62L++(bright) Phenotype Accumulate in a Subgroup of Older Adults and Are Associated with the Maintenance of Intact Humoral Immunity in Old Age
J. Immunol., January 1, 2003; 170(1): 613 - 619.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saurwein-Teissl, M.
Right arrow Articles by Grubeck-Loebenstein, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saurwein-Teissl, M.
Right arrow Articles by Grubeck-Loebenstein, B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS